ArticleAutophagy reports2023
A novel regulator of selective autophagy: TNIP1/ABIN-1 modulates mitophagy.
Article in Autophagy reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
TNIP1/ABIN-1 is a novel inhibitor of inflammation and cell death. In our study, we elucidated the MAP1LC3/LC3 (microtubule associated protein 1 light chain 3)-interacting region (LIR) 1 and 2 motifs of TNIP1-dependent direct binding to LC3B-II and subsequent colocalization on phagophores. In addition, TNIP1 colocalizes with LAMP1 (lysosomal associated membrane protein 1) on autolysosomes. Autophagic stimuli induce the translocation of TNIP1 to damaged mitochondria promoting the degradation of the mitochondrial outer membrane proteins VDAC1 (voltage dependent anion channel 1), MFN2 (mitofusin 2), and TOMM20 (translocase of outer mitochondrial membrane 20), together with its own degradation, possibly via the autophagic pathway. Knockdown of TNIP1 partially but significantly inhibits mitophagy. Thus, identification of TNIP1 as a novel selective mitophagy regulator promoting mitophagy would play a decisive role in understanding the pathophysiological outcome associated with diverse types of mitochondria-associated cellular stress.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.